| 時間 | 主題 | ||||
|---|---|---|---|---|---|
PD02-1: Mir-299-3p inhibits cell proliferation, motility and invasion through VEGFA in upper tract urothelial carcinoma
講者:
王建勝
座長:
蔡曜州, 鍾旭東 |
王建勝 |
蔡曜州, 鍾旭東 |
|||
PD02-2: The prognostic significance of ROR2 expression in patients with urothelial carcinoma
講者:
李威明
座長:
蔡曜州, 鍾旭東 |
李威明 |
蔡曜州, 鍾旭東 |
|||
PD02-3: Decreased Dehydrogenase/Reductase 2(DHRS2) expression is associated with poor prognosis in urothelial carcinoma patients
講者:
吳奕儒
座長:
蔡曜州, 鍾旭東 |
吳奕儒 |
蔡曜州, 鍾旭東 |
|||
PD02-4: Outcomes of chemotherapy agents as subsequent replacements for discontinued Bacillus Calmette-Guerin bladder instillation in bladder cancer
講者:
林柏廷
座長:
蔡曜州, 鍾旭東 |
林柏廷 |
蔡曜州, 鍾旭東 |
|||
PD02-5: Predictive factors of intravesical recurrence after radical nephroureterectomy for upper tract urothelial carcinoma
講者:
陳震亞
座長:
蔡曜州, 鍾旭東 |
陳震亞 |
蔡曜州, 鍾旭東 |
|||
PD02-6: The therapeutic potential of chemoradiotherapy combine with regional hyperthermia therapy for locally advanced bladder cancer- phase III clinical trial preliminary data report
講者:
王大齊
座長:
蔡曜州, 鍾旭東 |
王大齊 |
蔡曜州, 鍾旭東 |